HPV integration and cervical cancer: a failed evolutionary viral trait
- PMID: 38853085
- DOI: 10.1016/j.molmed.2024.05.009
HPV integration and cervical cancer: a failed evolutionary viral trait
Abstract
Countless efforts have been made to eradicate cervical cancer worldwide, including improving disease screening and human papillomavirus (HPV) vaccination programs. Nevertheless, cervical cancer still claims the lives of more than 300 000 women every year. Persistent infections with high-risk HPV genotypes 16 and 18 are the main cause of cancer and may result in HPV integration into the host genome. The central dogma is that HPV integration is an important step in oncogenesis, but in fact, it impedes the virus from replicating and spreading. HPV causing cervical cancer can therefore be perceived as a failed evolutionary viral trait. Here we outline the occurrence and mechanisms of HPV integration and how this process results in oncogenic transformation.
Keywords: E6; E7; HPV; HPV integration; cervical cancer; oncogenic transformation.
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare that they have no competing interests.
Similar articles
-
Understanding the HPV integration and its progression to cervical cancer.Infect Genet Evol. 2018 Jul;61:134-144. doi: 10.1016/j.meegid.2018.03.003. Epub 2018 Mar 6. Infect Genet Evol. 2018. PMID: 29518579 Review.
-
Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia.Mol Diagn. 2004;8(1):57-64. doi: 10.1007/BF03260048. Mol Diagn. 2004. PMID: 15230643
-
Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.Gynecol Oncol. 2004 Mar;92(3):873-80. doi: 10.1016/j.ygyno.2003.11.035. Gynecol Oncol. 2004. PMID: 14984955
-
Integrated human papillomavirus types 52 and 58 are infrequently found in cervical cancer, and high viral loads predict risk of cervical cancer.Gynecol Oncol. 2006 Jul;102(1):54-60. doi: 10.1016/j.ygyno.2005.11.035. Epub 2005 Dec 28. Gynecol Oncol. 2006. PMID: 16386784
-
[Epidemiology of cervical papillomavirus infections. Recent knowledge].Presse Med. 2001 Jun 9;30(20):1017-23. Presse Med. 2001. PMID: 11433694 Review. French.
Cited by
-
Risk assessment and triage strategy of cervical cancer primary screening on HPV integration status: 5-year follow-up of a prospective cohort study.J Natl Cancer Cent. 2024 Oct 16;4(4):311-317. doi: 10.1016/j.jncc.2024.08.001. eCollection 2024 Dec. J Natl Cancer Cent. 2024. PMID: 39735440 Free PMC article.
-
Advances in cervical cancer: current insights and future directions.Cancer Commun (Lond). 2025 Feb;45(2):77-109. doi: 10.1002/cac2.12629. Epub 2024 Nov 29. Cancer Commun (Lond). 2025. PMID: 39611440 Free PMC article. Review.
-
PAX1/SOX1 gene methylation as a detection and triage method for triage of high risk HPV-Positive women in cervical cancer screening.Gynecol Oncol Rep. 2025 Jun 30;60:101794. doi: 10.1016/j.gore.2025.101794. eCollection 2025 Aug. Gynecol Oncol Rep. 2025. PMID: 40687918 Free PMC article.
-
Genome Editing in Gynecological Oncology: The Emerging Role of CRISPR/Cas9 in Precision Cancer Therapy.Ther Innov Regul Sci. 2025 May 20. doi: 10.1007/s43441-025-00807-w. Online ahead of print. Ther Innov Regul Sci. 2025. PMID: 40394347 Review.
-
Prognostic value of circ_0000043/miR-590-5p in cervical cancer and regulation of tumor progression.Discov Oncol. 2025 May 23;16(1):879. doi: 10.1007/s12672-025-02670-5. Discov Oncol. 2025. PMID: 40407961 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical